Trials
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
193,990 genes from NCBI Gene. Counted 2026-11-11.
Most papers first1,621 to 1,640 of 193,990
| Gene | NCBI Gene | Proteins | Patents | Drugs | Trials | NIH grants | Papers |
|---|---|---|---|---|---|---|---|
| REST RE1 silencing transcription factor | 5978 HGNC:9966 | 1 | 36 | 0 | 0 | 3,592 | 4,251 |
| DRD1 dopamine receptor D1 | 1812 HGNC:3020 | 1 | 64 | 16 | 47 | 3,209 | 4,249 |
| PDLIM7 PDZ and LIM domain 7 | 9260 HGNC:22958 | 1 | 74 | 0 | 0 | 1,683 | 4,249 |
| DEFB4A defensin beta 4A | 1673 HGNC:2767 | 1 | 122 | 0 | 0 | 2,073 | 4,248 |
| PPY pancreatic polypeptide | 5539 HGNC:9327 | 1 | 73 | 0 | 0 | 1,759 | 4,248 |
| MYH9 myosin heavy chain 9 | 4627 HGNC:7579 | 1 | 90 | 0 | 0 | 2,904 | 4,242 |
| CHRM3 cholinergic receptor muscarinic 3 | 1131 HGNC:1952 | 1 | 61 | 82 | 1,177 | 3,784 | 4,237 |
| ISG20 interferon stimulated exonuclease gene 20 | 3669 HGNC:6130 | 1 | 49 | 0 | 0 | 2,395 | 4,236 |
| FCGR2B Fc gamma receptor IIb | 2213 HGNC:3618 | 1 | 145 | 1 | 5 | 2,625 | 4,232 |
| MUC4 mucin 4, cell surface associated | 4585 HGNC:7514 | 1 | 17 | 0 | 0 | 1,678 | 4,232 |
| CD82 CD82 molecule | 3732 HGNC:6210 | 1 | 52 | 0 | 0 | 1,625 | 4,224 |
| MIR204 microRNA 204 | 406987 HGNC:31582 | 0 | 0 | 0 | 0 | 1,189 | 4,222 |
| FKBP5 FKBP prolyl isomerase 5 | 2289 HGNC:3721 | 1 | 77 | 0 | 0 | 3,378 | 4,216 |
| POLD1 DNA polymerase delta 1, catalytic subunit | 5424 HGNC:9175 | 1 | 20 | 7 | 4,186 | 2,256 | 4,215 |
| GOLPH3 golgi phosphoprotein 3 | 64083 HGNC:15452 | 1 | 23 | 0 | 0 | 970 | 4,211 |
| IRF5 interferon regulatory factor 5 | 3663 HGNC:6120 | 1 | 72 | 0 | 0 | 2,893 | 4,211 |
| CNTN2 contactin 2 | 6900 HGNC:2172 | 1 | 71 | 0 | 0 | 2,058 | 4,207 |
| RPLP0 ribosomal protein lateral stalk subunit P0 | 6175 HGNC:10371 | 1 | 95 | 9 | 38 | 2,549 | 4,207 |
| ABCC8 ATP binding cassette subfamily C member 8 | 6833 HGNC:59 | 1 | 20 | 15 | 277 | 2,070 | 4,205 |
| MUC5B mucin 5B, oligomeric mucus/gel-forming | 727897 HGNC:7516 | 1 | 49 | 0 | 0 | 2,583 | 4,205 |
Response
The first 2 of this page's 20 results. GET /api/genes/v1?page=82
{
"data": {
"total": 193990,
"results": [
{
"id": "5978",
"title": "REST: RE1 silencing transcription factor",
"summary": "NCBI Gene 5978. 1 protein, 36 patents, 0 drugs, 0 trials, 3,592 NIH grants and 4,251 papers.",
"record": "/library/genes/5978",
"gene_id": 5978,
"symbol": "REST",
"name": "RE1 silencing transcription factor",
"hgnc_id": "HGNC:9966",
"counts": {
"proteins": 1,
"patents": 36,
"drugs": 0,
"trials": 0,
"grants": 3592,
"papers": 4251
}
},
{
"id": "1812",
"title": "DRD1: dopamine receptor D1",
"summary": "NCBI Gene 1812. 1 protein, 64 patents, 16 drugs, 47 trials, 3,209 NIH grants and 4,249 papers.",
"record": "/library/genes/1812",
"gene_id": 1812,
"symbol": "DRD1",
"name": "dopamine receptor D1",
"hgnc_id": "HGNC:3020",
"counts": {
"proteins": 1,
"patents": 64,
"drugs": 16,
"trials": 47,
"grants": 3209,
"papers": 4249
}
}
],
"columns": [
{
"key": "symbol",
"label": "Gene",
"under": "name"
},
{
"key": "id",
"label": "NCBI Gene",
"under": "hgnc_id"
},
{
"key": "counts.proteins",
"label": "Proteins"
},
{
"key": "counts.patents",
"label": "Patents"
},
{
"key": "counts.drugs",
"label": "Drugs"
},
{
"key": "counts.trials",
"label": "Trials"
},
{
"key": "counts.grants",
"label": "NIH grants"
},
{
"key": "counts.papers",
"label": "Papers"
}
],
"order": "Most papers first"
},
"release": "gene-search-2026-11-11-0.1.0",
"terms": [
{
"source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
"license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "Freely available. Acknowledgement requested"
},
{
"source": "ChEMBL, through Open Targets",
"license": "CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC BY-SA 3.0"
},
{
"source": "ClinicalTrials.gov",
"license": "none stated",
"notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.",
"short": "None stated"
},
{
"source": "EMBL-EBI's patent proteins",
"license": "EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: \"EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners\" and \"EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools.\" Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use",
"notice": null,
"short": "No added restrictions. Attribution expected"
},
{
"source": "GenBank's patent files",
"license": "GenBank's patent files. NCBI: \"NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted.\" Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/",
"notice": null,
"short": "No restrictions from NCBI. Submitters may hold rights"
},
{
"source": "HGNC",
"license": "CC0: https://www.genenames.org/about/license/",
"notice": null,
"short": "CC0"
},
{
"source": "NCBI Gene",
"license": "None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/",
"notice": null,
"short": "None named. Public domain as US government information"
},
{
"source": "NIH's project files and grant-paper links",
"license": "Public domain (NIH RePORTER)",
"notice": null,
"short": "Public domain"
},
{
"source": "Open Targets",
"license": "CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence",
"notice": null,
"short": "CC0 1.0"
},
{
"source": "PubTator 3",
"license": "Public domain",
"notice": null,
"short": "Public domain"
},
{
"source": "UniProt",
"license": "CC BY 4.0. UniProt's licence file: \"All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy.\" UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license",
"notice": null,
"short": "CC BY 4.0"
}
],
"next": "/api/genes/v1?page=83",
"request_id": "JH8aSMhbsowsDocX"
}ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov
Search clinical trials by condition, drug, outcome or NCT number, with the results each one posted.
ClinicalTrials.gov
Comparisons of the groups of clinical trials, such as a risk ratio or a number needed to treat, calculated from the counts each trial posted.
Patent publications
Paste a sequence and see the patents that disclose it.
For invited accounts.
Opens sequences.conductscience.org
For software
Every answer on this page is also JSON, under /api/genes/v1. No key.
GET https://conductscience.org/api/genes/v1?q=p53
Ask an assistant